p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients-Reference-Cited by-同舟云学术

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients

Published:2011-01-20 Issue:1 Volume:13 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Bourdon Jean-Christophe,Khoury Marie P,Diot Alexandra,Baker Lee,Fernandes Kenneth,Aoubala Mustapha,Quinlan Philip,Purdie Colin A,Jordan Lee B,Prats Anne-Catherine,Lane David P,Thompson Alastair M

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr2811.pdf

Reference24 articles.

1. Vousden KH, Lane DP: p53 in health and disease. Nat Rev Mol Cell Biol. 2007, 8: 275-283. 10.1038/nrm2147.

2. Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M: TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007, 26: 2157-2165. 10.1038/sj.onc.1210302.

3. Olivier M, Petitjean A, Marcel V, Pétré A, Mounawar M, Plymoth A, de Fromentel CC, Hainaut P: Recent advances in p53 research: an interdisciplinary perspective. Cancer Gene Ther. 2009, 16: 1-12. 10.1038/cgt.2008.69.

4. Olivier M, Langerød A, Carrieri P, Bergh J, Klaar S, Eyfjord J, Theillet C, Rodriguez C, Lidereau R, Bièche I, Varley J, Bignon Y, Uhrhammer N, Winqvist R, Jukkola-Vuorinen A, Niederacher D, Kato S, Ishioka C, Hainaut P, Børresen-Dale AL: The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res. 2006, 12: 1157-1167. 10.1158/1078-0432.CCR-05-1029.

5. Aas T, Børresen AL, Geisler S, Smith-Sørensen B, Johnsen H, Varhaug JE, Akslen LA, Lønning PE: Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med. 1996, 2: 811-814. 10.1038/nm0796-811.

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications;Biomedicines;2024-06-29

2. Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance;Cell Death & Disease;2024-06-12

3. Combining TP53 mutation and isoform has the potential to improve clinical practice;Pathology;2024-06

4. Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment;Cancers;2023-09-27

5. Dysregulation of P53 in breast cancer: Causative factors and treatment strategies;Pathology - Research and Practice;2023-07